Wells Fargo downgrades Pharmaceutical Product Development (Nasdaq: PPDI) from Outperform to Market Perform. Lowers valuation range to $21-23 from $26-27 ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE